Immunophenotypic characterization of human fetal liver hematopoietic stem cells during the midtrimester of gestation

J. M. Gilles, M. Y. Divon, E. Bentolila, Ohad D. Rotenberg, D. F. Gebhard, W. K. Rashbaum, W. D. Lyman

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

OBJECTIVE: Our purpose was to define the extent to which gestational age influences the number of fetal liver cells that coexpress phenotypic markers associated with hematopoietic stem cells and major histocompatibility antigens. STUDY DESIGN: Fetal liver cells from abortuses of 9 to 24 weeks of gestation were studied (n = 61). Low-density nucleated liver cells were isolated on a discontinuous density gradient and subsequently incubated with antibodies that recognize markers of hematopoietic stem cells (i.e., CD33, CD34, CDw90, CD117, and CD123). Human leukocyte antigen class I (A, B, C) and class II (DR) antigens were also determined on these cells. Each sample was analyzed by immunocytochemistry and flow cytometry. Analysis of variance was used for statistical analysis. RESULTS: Of the markers measured only the percentage of CD123-positive cells increased significantly with gestational age (p < 0.01). The percentage of triple-positive cells (CD34+, CD117+, and CD123+) increased with age but did not reach significance (p = 0.05). Human leukocyte A, B and C antigens were expressed on all nucleated cells from 9 to 24 weeks of gestation. Human leukocyte DR antigen, however was expressed only on 50% of these cells. The percentage of cells that expressed both hematopoietic stem cell markers and DR antigen did not vary with gestational age. CONCLUSIONS: From 9 to 24 weeks of gestation the number of human fetal liver hematopoietic stem cells that coexpress major histocompatibility antigens increases with advancing gestational age, largely because the percentage of these cells remains constant while the liver mass increases.

Original languageEnglish (US)
Pages (from-to)619-625
Number of pages7
JournalAmerican Journal of Obstetrics and Gynecology
Volume177
Issue number3
DOIs
StatePublished - 1997

Fingerprint

Second Pregnancy Trimester
Hematopoietic Stem Cells
Pregnancy
Liver
Gestational Age
Histocompatibility Antigens
HLA Antigens
Histocompatibility Antigens Class II
Differentiation Antigens
Analysis of Variance
Flow Cytometry
Leukocytes
Immunohistochemistry
Antigens
Antibodies

Keywords

  • Differentiation markers
  • Hematopoiesis
  • Human fetus
  • Human leukocyte antigens
  • Stem cells

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Immunophenotypic characterization of human fetal liver hematopoietic stem cells during the midtrimester of gestation. / Gilles, J. M.; Divon, M. Y.; Bentolila, E.; Rotenberg, Ohad D.; Gebhard, D. F.; Rashbaum, W. K.; Lyman, W. D.

In: American Journal of Obstetrics and Gynecology, Vol. 177, No. 3, 1997, p. 619-625.

Research output: Contribution to journalArticle

Gilles, J. M. ; Divon, M. Y. ; Bentolila, E. ; Rotenberg, Ohad D. ; Gebhard, D. F. ; Rashbaum, W. K. ; Lyman, W. D. / Immunophenotypic characterization of human fetal liver hematopoietic stem cells during the midtrimester of gestation. In: American Journal of Obstetrics and Gynecology. 1997 ; Vol. 177, No. 3. pp. 619-625.
@article{5187b4b429ff4d3190c479a0a375c025,
title = "Immunophenotypic characterization of human fetal liver hematopoietic stem cells during the midtrimester of gestation",
abstract = "OBJECTIVE: Our purpose was to define the extent to which gestational age influences the number of fetal liver cells that coexpress phenotypic markers associated with hematopoietic stem cells and major histocompatibility antigens. STUDY DESIGN: Fetal liver cells from abortuses of 9 to 24 weeks of gestation were studied (n = 61). Low-density nucleated liver cells were isolated on a discontinuous density gradient and subsequently incubated with antibodies that recognize markers of hematopoietic stem cells (i.e., CD33, CD34, CDw90, CD117, and CD123). Human leukocyte antigen class I (A, B, C) and class II (DR) antigens were also determined on these cells. Each sample was analyzed by immunocytochemistry and flow cytometry. Analysis of variance was used for statistical analysis. RESULTS: Of the markers measured only the percentage of CD123-positive cells increased significantly with gestational age (p < 0.01). The percentage of triple-positive cells (CD34+, CD117+, and CD123+) increased with age but did not reach significance (p = 0.05). Human leukocyte A, B and C antigens were expressed on all nucleated cells from 9 to 24 weeks of gestation. Human leukocyte DR antigen, however was expressed only on 50{\%} of these cells. The percentage of cells that expressed both hematopoietic stem cell markers and DR antigen did not vary with gestational age. CONCLUSIONS: From 9 to 24 weeks of gestation the number of human fetal liver hematopoietic stem cells that coexpress major histocompatibility antigens increases with advancing gestational age, largely because the percentage of these cells remains constant while the liver mass increases.",
keywords = "Differentiation markers, Hematopoiesis, Human fetus, Human leukocyte antigens, Stem cells",
author = "Gilles, {J. M.} and Divon, {M. Y.} and E. Bentolila and Rotenberg, {Ohad D.} and Gebhard, {D. F.} and Rashbaum, {W. K.} and Lyman, {W. D.}",
year = "1997",
doi = "10.1016/S0002-9378(97)70155-8",
language = "English (US)",
volume = "177",
pages = "619--625",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Immunophenotypic characterization of human fetal liver hematopoietic stem cells during the midtrimester of gestation

AU - Gilles, J. M.

AU - Divon, M. Y.

AU - Bentolila, E.

AU - Rotenberg, Ohad D.

AU - Gebhard, D. F.

AU - Rashbaum, W. K.

AU - Lyman, W. D.

PY - 1997

Y1 - 1997

N2 - OBJECTIVE: Our purpose was to define the extent to which gestational age influences the number of fetal liver cells that coexpress phenotypic markers associated with hematopoietic stem cells and major histocompatibility antigens. STUDY DESIGN: Fetal liver cells from abortuses of 9 to 24 weeks of gestation were studied (n = 61). Low-density nucleated liver cells were isolated on a discontinuous density gradient and subsequently incubated with antibodies that recognize markers of hematopoietic stem cells (i.e., CD33, CD34, CDw90, CD117, and CD123). Human leukocyte antigen class I (A, B, C) and class II (DR) antigens were also determined on these cells. Each sample was analyzed by immunocytochemistry and flow cytometry. Analysis of variance was used for statistical analysis. RESULTS: Of the markers measured only the percentage of CD123-positive cells increased significantly with gestational age (p < 0.01). The percentage of triple-positive cells (CD34+, CD117+, and CD123+) increased with age but did not reach significance (p = 0.05). Human leukocyte A, B and C antigens were expressed on all nucleated cells from 9 to 24 weeks of gestation. Human leukocyte DR antigen, however was expressed only on 50% of these cells. The percentage of cells that expressed both hematopoietic stem cell markers and DR antigen did not vary with gestational age. CONCLUSIONS: From 9 to 24 weeks of gestation the number of human fetal liver hematopoietic stem cells that coexpress major histocompatibility antigens increases with advancing gestational age, largely because the percentage of these cells remains constant while the liver mass increases.

AB - OBJECTIVE: Our purpose was to define the extent to which gestational age influences the number of fetal liver cells that coexpress phenotypic markers associated with hematopoietic stem cells and major histocompatibility antigens. STUDY DESIGN: Fetal liver cells from abortuses of 9 to 24 weeks of gestation were studied (n = 61). Low-density nucleated liver cells were isolated on a discontinuous density gradient and subsequently incubated with antibodies that recognize markers of hematopoietic stem cells (i.e., CD33, CD34, CDw90, CD117, and CD123). Human leukocyte antigen class I (A, B, C) and class II (DR) antigens were also determined on these cells. Each sample was analyzed by immunocytochemistry and flow cytometry. Analysis of variance was used for statistical analysis. RESULTS: Of the markers measured only the percentage of CD123-positive cells increased significantly with gestational age (p < 0.01). The percentage of triple-positive cells (CD34+, CD117+, and CD123+) increased with age but did not reach significance (p = 0.05). Human leukocyte A, B and C antigens were expressed on all nucleated cells from 9 to 24 weeks of gestation. Human leukocyte DR antigen, however was expressed only on 50% of these cells. The percentage of cells that expressed both hematopoietic stem cell markers and DR antigen did not vary with gestational age. CONCLUSIONS: From 9 to 24 weeks of gestation the number of human fetal liver hematopoietic stem cells that coexpress major histocompatibility antigens increases with advancing gestational age, largely because the percentage of these cells remains constant while the liver mass increases.

KW - Differentiation markers

KW - Hematopoiesis

KW - Human fetus

KW - Human leukocyte antigens

KW - Stem cells

UR - http://www.scopus.com/inward/record.url?scp=0030817016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030817016&partnerID=8YFLogxK

U2 - 10.1016/S0002-9378(97)70155-8

DO - 10.1016/S0002-9378(97)70155-8

M3 - Article

VL - 177

SP - 619

EP - 625

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 3

ER -